yttrium radioisotopes has been researched along with B16 Melanoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Aluicio-Sarduy, E; Arthur, IS; Barnhart, TE; Bates, AM; Bednarz, BP; Brown, RJ; Carlson, PM; Chakravarty, I; Emma, SE; Engle, JW; Grudzinski, JJ; Hernandez, R; Jagodinsky, JC; Jin, WJ; Kerr, C; Kim, K; Le, T; Marsh, IR; Morris, ZS; Nystuen, EJ; Patel, RB; Sriramaneni, RN; Weichert, JP; Zangl, LM | 1 |
Ballard, B; Cutler, CS; Dadachova, E; Francesconi, LC; Jiang, Z; Miller, WH; Revskaya, E; Sisay, N; Thompson, S | 1 |
Chakravarty, R; Dash, A; Kumar, Y; Pandey, U; Sarma, HD; Saxena, SK | 1 |
Lewis, JS; McQuade, P; Miao, Y; Quinn, TP; Welch, MJ; Yoo, J | 1 |
Hoffman, TJ; Miao, Y; Quinn, TP | 1 |
Fischer, T; Franke, WG; Hientzsch, B; Jantsch, K; Limouris, G; Scharl, A; Scheidhauer, K; Schicha, H; Schomäcker, K; Shukla, SK | 1 |
Franke, WG; Hientzsch, B; Jantsch, K; Limouris, G; Scharl, A; Scheidhauer, K; Schicha, H; Schomäker, K; Shukla, SK | 1 |
7 other study(ies) available for yttrium radioisotopes and B16 Melanoma
Article | Year |
---|---|
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Head and Neck Neoplasms; Immune Checkpoint Inhibitors; Interferon Type I; Lymphocytes; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Radiopharmaceuticals; Time Factors; Tumor Protein, Translationally-Controlled 1; Tumor Stem Cell Assay; Up-Regulation; Yttrium Radioisotopes | 2021 |
166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Drug Stability; Female; Half-Life; Holmium; Humans; Melanoma, Experimental; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Tissue Distribution; Yttrium Radioisotopes | 2014 |
On the application of Nafion membrane for the preparation of (90)Y skin patches, quality control, and biological evaluation for treatment of superficial tumors.
Topics: Animals; Fluorocarbon Polymers; Melanoma, Experimental; Membranes, Artificial; Mice; Mice, Inbred C57BL; Quality Control; Radiopharmaceuticals; Random Allocation; Skin Neoplasms; Transdermal Patch; Yttrium Radioisotopes | 2014 |
Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
Topics: alpha-MSH; Animals; Cell Line, Tumor; Copper Radioisotopes; Female; Isotope Labeling; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organometallic Compounds; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Melanocortin, Type 1; Structure-Activity Relationship; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 2005 |
Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.
Topics: alpha-MSH; Animals; Female; Lutetium; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Radiopharmaceuticals; Yttrium Radioisotopes | 2005 |
[Biokinetics of tumor-affinity yttrium preparations--2].
Topics: Animals; Calcium; Female; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred Strains; Radionuclide Imaging; Reference Values; Tissue Distribution; Yttrium Radioisotopes | 1995 |
[Biokinetics of tumor-affinity yttrium preparations--Part 1].
Topics: Animals; Calcium; Citrates; Kinetics; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred Strains; Organometallic Compounds; Radionuclide Imaging; Tissue Distribution; Yttrium Radioisotopes | 1995 |